The report talks about the shift in demands and emerging trends that are expected to drive the growth of the Autoinjectors market. The rising demand for the Autoinjectors market is expected to drive the demand for Autoinjectors market, thereby bolstering the growth of the industry. Moreover, the report also studies the impact of the COVID-19 pandemic on the market.
The global autoinjectors market size is expected to reach USD 170.16 Billion in 2028 at a steady CAGR, according to latest analysis by Emergen Research. Global autoinjectors market revenue growth is significantly driven by increasing preference for self-administration of drugs, rapid increase in global geriatric population, and major prevalence of anaphylaxis, rheumatoid arthritis, and diabetes. Autoinjector devices are designed to eliminate hesitation during self-administration of drugs while using needle-based delivery systems. Majority of devices are pen-shaped and equipped with a hypodermic needle. The drug is delivered by inserting the syringe at the required site of injection and pushing a button.
Autoinjector devices are commonly used to treat different conditions such as multiple sclerosis, anaphylaxis, diabetes, rheumatoid arthritis, and others. These devices offer multiple benefits over conventional processes and offer higher accuracy and efficacy, lower risk of needlestick injuries, consistent delivery of dosage, and others.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/678
The report also profiles established and emerging players of the market, covering the business overview, product portfolio, strategic alliances, and business expansion strategies.
Key players operating in the market are Braun Melsungen AG, AbbVie Inc., Mylan, Eli Lilly and Company, Ypsomed, Amgen, Becton, Dickinson and Company, GlaxoSmithKline plc, Johnson Johnson, and Antares Pharma.
Key Points of Autoinjectors Market:
- Industrial structure analysis of the Autoinjectors market by identification of various sub-segments
- Extensive analysis of key market players along with their SWOT analysis
- Competitive landscape benchmarking
- Analysis of Autoinjectors market based on growth trends, futuristic outlook, and contribution to the total growth of the market
- Analysis of drivers, constraints, opportunities, challenges, and risks in the global Autoinjectors market
- Comprehensive analysis of competitive developments such as expansions, agreements,
Request a discount on the report @ https://www.emergenresearch.com/request-discount/678
The report studies the historical data of the Autoinjectors Market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects.
For the purpose of this report, Emergen Research has segmented the global autoinjectors market based on therapy, type, route of administration, end-use, and region:
Therapy Outlook (Revenue, USD Billion; 2018–2028)
- Rheumatoid Arthritis
- Multiple Sclerosis
- Anaphylaxis
- Diabetes
- Others
Type Outlook (Revenue, USD Billion; 2018–2028)
- Disposable
- Reusable
Route of Administration Outlook (Revenue, USD Billion; 2018-2028)
- Subcutaneous
- Intramuscular
End-Use Outlook (Revenue, USD Billion; 2018–2028)
- Hospitals Clinics
- Ambulatory Surgical Centers
- Home Care Settings
The complete regional analysis covers:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/678
Key Points of Autoinjectors Market:
- In March 2020, SHL Medical acquired Weibel CDS. The acquisition helped SHL Medical to strengthen its ability to offer more advanced drug delivery systems based on human-centered functionality and designs.
- Rheumatoid arthritis segment revenue is expected to register a 17.9% CAGR throughout the forecast period. Major prevalence of rheumatoid arthritis is a key factor driving revenue growth of this segment.
- Asia Pacific is expected to register the fastest revenue CAGR throughout the forecast period. Increasing geriatric population, development of more modernized healthcare infrastructure, and major prevalence of diabetes are some key factors propelling revenue growth of the market in this region.
Thank you for reading our report. Customization of the report is available. To know more, please connect with us, and our team will ensure the report is customized as per your requirements.
Take a Look at our Related Reports:
injectable drug delivery market
https://www.emergenresearch.com/industry-report/injectable-drug-delivery-market
gene editing market
https://www.emergenresearch.com/industry-report/gene-editing-market
anti-reflective coatings market
https://www.emergenresearch.com/industry-report/anti-reflective-coatings-market
peritoneal dialysis market
https://www.emergenresearch.com/industry-report/peritoneal-dialysis-market
thin wall packaging market
https://www.emergenresearch.com/industry-report/thin-wall-packaging-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Latest Reports: c5isr systems market | peritoneal dialysis market
Trending Titles: ai in banking market | 5g fixed wireless access market
